Haoxi Health Technology (NASDAQ:HAO) Stock Rating Lowered by Wall Street Zen

Haoxi Health Technology (NASDAQ:HAO) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Sunday.

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Haoxi Health Technology in a research report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Haoxi Health Technology Stock Down 8.0%

Shares of NASDAQ HAO opened at $3.01 on Friday. The firm’s 50-day moving average price is $10.23 and its 200-day moving average price is $1,327.82. Haoxi Health Technology has a 52-week low of $2.70 and a 52-week high of $5,708.80.

Haoxi Health Technology Company Profile

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.